$9.07
-0.44-4.63%
At close: Dec 15, 4:00 PM EST
$8.65
-0.42-4.68%
After Hours: 4:29 PM EST
Comments
Loading...
TransCode Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:RNAZ | Benzinga
TransCode Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-5.820
Quarterly Revenue
$0.00
Annual Revenue
(as of Sep 30)
(as of Sep 30)
–
Analyze the earnings history of TransCode Therapeutics using advanced sorting and filters.
TransCode Therapeutics (RNAZ) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | 2025-05-14 | $-70.28 | $-41.44 | -69.6 % |
| Q4 | 2025-04-15 | $-201.88 | $-3.21 | -6189.1 % |
| Q3 | 2024-11-14 | $-147.84 | $-452.76 | 67.3 % |
| Q2 | 2024-08-14 | $-683.76 | $-535.92 | -27.6 % |
TransCode Therapeutics (RNAZ) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-04-15 | $0 | $300.00K | -100.0 % |
| Q3 | 2024-11-14 | $0 | $300.00K | -100.0 % |
FAQ
When is TransCode Therapeutics (NASDAQ:RNAZ) reporting earnings?
TransCode Therapeutics (RNAZ) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2025 for Q3.
What were the latest earnings per share (EPS) for TransCode Therapeutics (NASDAQ:RNAZ)?
TransCode Therapeutics (RNAZ) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2025 for Q3 and the Actual EPS was $-5.82, which missed the estimate of $0.00.
What were TransCode Therapeutics’s (NASDAQ:RNAZ) revenues?
TransCode Therapeutics (RNAZ) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2025 for Q3 and the Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.
